The latest market evaluation report on the RNA Transcriptomics market explores how the RNA Transcriptomics market will continue to expand for the forecast period 2020 - 2027. The study further serves as a unique research for stakeholders, product owners, and field marketing executives looking for actionable data and unique resource on market size, share, and growth. The market intelligence report gives business evangelists an authority to review the major trends, opportunities, and challenges expected to shape the future of the industry during the estimated period. Importantly, the study not only helps spot the major vendors but also their winning strategies

RNA transcriptome analysis helps researchers to understand the distribution of genes and functional patterns of each gene present in an organism. This analysis assesses all elements of a transcript, such as non-coding RNAs, mRNAs, and microRNAs, to identify the transcriptional structure of genes and quantify each transcript's changing behavior at the development stage.Rising prevalence of cancer, diabetes, and hepatitis B, and growing focus on various drug development initiatives are key factors boosting revenue growth of the global market        

Get a Free sample of the report : https://www.emergenresearch.com/request-sample/610

Additionally, the report also gives an insight into product portfolios, costs, sales, production capacities, and market players. Raw materials, demand analysis, product flow, and distribution channels have been studied and surveyed extensively in this research report. The key growth trends and opportunities are offered through a thorough investigation and examination of the market. A detailed course of development is offered in the report along with insights into businesses connected with it, which include firms, industries, organizations, vendors, and local manufacturers.

Commonly applied transcriptome analysis methods are hybridization-based microarray, real-time PCR, NGS-based RNA-sequencing (RNA-seq) methods, RNA interference, and bioinformatics tools. Growing need to analyze a large number of genes to better understand gene-to-drug interactions is expected to increase the application of transcriptomic technologies in drug development and discovery applications.

In October 2019, Ambry Genetics introduced a transcriptomic test +RNAinsight, which allows clinicians to simultaneously perform RNA and DNA testing and identify the risk of genetic mutations that may develop cancer.

Reagents segment is expected to register a revenue CAGR of 14.0% over the forecast period. This can be attributed to rising demand for high-quality reagents and growing research and development activities in the pharmaceutical sector.

Asia Pacific market revenue is expected to continue to register the fastest CAGR throughout the forecast period, which can be attributed to rising number of biotechnology and pharmaceutical companies and increasing focus on drug development.

Key players operating in the market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Illumina, Inc., GenXPro GmbH, Fluidigm Corporation, CD Genomics, Sequentia Biotech SL, and Acobiom.

The severe global crisis has prompted organizations to efficiently respond to the rapidly shifting business environment. Therefore, the report fully covers the profound impact of COVID-19 on this industry, with a special focus on the affected industry segments. However, the market is expected to regain momentum in the post-COVID-19 era. The report also offers an initial and future impact assessment of the pandemic on the RNA Transcriptomics industry. Hence, the vital COVID-19 insights offered by the report are expected to help organizations manage their businesses effectively in extreme economic uncertainties.

Global RNA Transcriptomics Market Report – Table of Contents:

Chapter 1 includes the global RNA Transcriptomics market introduction, followed by the market scope, product offerings, growth opportunities, market risks, driving forces, and others.

Chapter 2 broadly categorizes the RNA Transcriptomics market on the basis of geography, and determines the sales, revenue, and market shares of each region over the estimated period.

Chapter 3 elaborates on the competitive outlook of the RNA Transcriptomics market, focusing on the major manufacturers and vendor landscape.

Chapter 4 exhaustively studies the key manufacturers of the RNA Transcriptomics industry, along with their anticipated sales and revenue shares.

Chapters 5 includes market segmentation based on product type, application range, and market players.

Request customization of the report: https://www.emergenresearch.com/request-for-customization/610

For the purpose of this report, Emergen Research has segmented the global RNA transcriptomics market based on product, technology, application, end-use, and region:

Product Outlook (Revenue: USD Billion; 2018–2028)

• Reagents
• Instruments
• Software
• Service

Technology Outlook (Revenue: USD Billion; 2018–2028)

• Microarrays
• Polymerase Chain Reaction
• RNA Sequencing
• RNA Interference

Application Outlook (Revenue: USD Billion; 2018–2028)

• Clinical Diagnostics
  1. Toxicogenomics
  2. Drug Discovery
  3. Comparative Transcriptomics

End-use Outlook (Revenue: USD Billion; 2018–2028)

• Hospitals
• Academic Research Institutes
• Pharmaceutical Biotechnology Companies
• Contract Research Organizations

Regional Outlook (Revenue: USD Billion; 2018–2028)

• North America
  1. U.S.
  2. Canada
  3. Mexico
• Europe
  1. Germany
  2. France
  3. U.K.
  4. BENELUX
  5. Italy
  6. Spain
  7. Russia
  8. Rest of Europe
• Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. India
  5. Rest of APAC
• Latin America
  1. Brazil
  2. Rest of LATAM
• Middle East Africa
  1. Saudi Arabia
  2. UAE
  3. South Africa
  4. Turkey
  5. Rest of MEA

Read More: https://www.emergenresearch.com/industry-report/rna-transcriptomics-market

Related Reports:

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research    and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs